Welcome to Eye Open

The aim of Eye Open is to provide a broad spectrum of content which complements that of its sister journal Eye, in line with the changing concepts in scientific publishing.It is not a replacement for Eye, which is doing very well.Eye Open aims to be global, translational, and cutting edge.We hope it will be a deserving home for manuscripts from all over the world, including The Royal College of Ophthalmologists' membership, and the global ophthalmology and allied professions communities.The journal will offer open access to practising ophthalmologists, allied health professionals, and vision science researchers, providing them with the latest clinical and laboratory findings.The range of article types would be broader than that of Eye, including laboratory investigations, a variety of clinical studies, (such as pilot studies, phase 1 and 2, validation studies, and service improvement research), as well as studies with negative results.Case reports, however, are only of interest if they are exceptional!Many institutions, including universities and clinical research networks, will cover researchers' Open Access fees through agreements with Springer Nature.Details available at https:// www.springernature.com/gp/open-science/oa-agreements.In addition, discounts are available for authors from developing economies.As with any new journal, the early years (particularly the first 2 years), pose challenges including the lack of indexing in databases such as PubMed.There is nothing to index without published articles!However, such challenges are short-term, developmental and are surmountable.Regular publication of good content (meeting minimum standards) over the early years will help achieve that aim of indexing quickly.I am optimistic that our potential authors will avail themselves of the immense opportunities of publishing in this new journal.We also welcome applications from qualified individuals who are interested in joining the Eye Open editorial board.We are particularly keen to hear from those with a strong background in relevant fields and a passion for contributing to the development and direction of our new journal.This is a valuable opportunity to play an active role in shaping editorial content and supporting our mission.Knowledge in ophthalmology and vision science has continued to evolve over the years, driven by advancements in imaging, treatments, genetics, artificial intelligence (AI), and metabolomics/oculomics.These developments are being embraced worldwide leading to a transformation of clinical ophthalmic care.The transformation will continue apace for the foreseeable future.However, eye care service delivery and service models continue to vary across jurisdictions, and are dependent on funding, and capacity demands and supply.Eye Open welcomes manuscripts, especially case studies, that address these issues.As eye care services continue to expand, it remains our responsibility to adapt practices accordingly.Manpower shortage is a particular problem in some jurisdictions, including the UK, leading to the diversification of the ophthalmology workforce.Despite this, the basic principle remains that ophthalmology services should be led and delivered by ophthalmologists.

Authors

Institutions

Publication Details

Journal
Eye Open
Published
2025-05-27
DOI
https://doi.org/10.1038/s44440-025-00004-6
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Welcome to Eye Open

Winfried M. K. Amoaku
Eye Open
Retinal Diseases and Treatments
article

Welcome to Eye Open

Winfried M. K. Amoaku
article en

Abstract

The aim of Eye Open is to provide a broad spectrum of content which complements that of its sister journal Eye, in line with the changing concepts in scientific publishing.It is not a replacement for Eye, which is doing very well.Eye Open aims to be global, translational, and cutting edge.We hope it will be a deserving home for manuscripts from all over the world, including The Royal College of Ophthalmologists' membership, and the global ophthalmology and allied professions communities.The journal will offer open access to practising ophthalmologists, allied health professionals, and vision science researchers, providing them with the latest clinical and laboratory findings.The range of article types would be broader than that of Eye, including laboratory investigations, a variety of clinical studies, (such as pilot studies, phase 1 and 2, validation studies, and service improvement research), as well as studies with negative results.Case reports, however, are only of interest if they are exceptional!Many institutions, including universities and clinical research networks, will cover researchers' Open Access fees through agreements with Springer Nature.Details available at https:// www.springernature.com/gp/open-science/oa-agreements.In addition, discounts are available for authors from developing economies.As with any new journal, the early years (particularly the first 2 years), pose challenges including the lack of indexing in databases such as PubMed.There is nothing to index without published articles!However, such challenges are short-term, developmental and are surmountable.Regular publication of good content (meeting minimum standards) over the early years will help achieve that aim of indexing quickly.I am optimistic that our potential authors will avail themselves of the immense opportunities of publishing in this new journal.We also welcome applications from qualified individuals who are interested in joining the Eye Open editorial board.We are particularly keen to hear from those with a strong background in relevant fields and a passion for contributing to the development and direction of our new journal.This is a valuable opportunity to play an active role in shaping editorial content and supporting our mission.Knowledge in ophthalmology and vision science has continued to evolve over the years, driven by advancements in imaging, treatments, genetics, artificial intelligence (AI), and metabolomics/oculomics.These developments are being embraced worldwide leading to a transformation of clinical ophthalmic care.The transformation will continue apace for the foreseeable future.However, eye care service delivery and service models continue to vary across jurisdictions, and are dependent on funding, and capacity demands and supply.Eye Open welcomes manuscripts, especially case studies, that address these issues.As eye care services continue to expand, it remains our responsibility to adapt practices accordingly.Manpower shortage is a particular problem in some jurisdictions, including the UK, leading to the diversification of the ophthalmology workforce.Despite this, the basic principle remains that ophthalmology services should be led and delivered by ophthalmologists.

Eye OpenVol. 1(1)
Queen's Medical Centre (GB)
Openalex Percentile: Top 81%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.